BioAffinity Technologies EBITDA vs. Net Income
The market value of BioAffinity Technologies is measured differently than book value, which reflects BioAffinity accounting equity. Intrinsic value is an analytical estimate of BioAffinity Technologies' underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
Note that BioAffinity Technologies' intrinsic value and market price are different measures derived from different inputs. For BioAffinity Technologies, key inputs include a profit margin of -2.17%, ROE of -2.45%, and revenue of 9.36 M. Market price reflects the current exchange level formed by active bids and offers.
BioAffinity Technologies Net Income vs. EBITDA Fundamental Analysis
Comparative ratio models evaluate BioAffinity Technologies's market value against peer multiples. bioAffinity Technologies Warrant is rated below average. in ebitda category among its top competitors. It is rated below average. in net income category among its top competitors . EBITDA is dropping compared to historical levels. BioAffinity Technologies reported -7.5 Million in EBITDA for the previous period. Comparative pricing ratios position BioAffinity Technologies within industry norms.BioAffinity Net Income vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
BioAffinity Technologies |
| = | -8.33 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
BioAffinity Technologies |
| = | -9.04 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
BioAffinity Net Income Comparison
BioAffinity Technologies is currently under evaluation. in net income category among its top competitors.
BioAffinity Technologies Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioAffinity Technologies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioAffinity Technologies will eventually generate negative long term returns. The profitability progress is the general direction of BioAffinity Technologies' change in net profit over the period of time. It can combine multiple indicators of BioAffinity Technologies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -3.6 M | -3.8 M | |
| Operating Income | -8.1 M | -7.7 M | |
| Income Before Tax | -8.1 M | -8.5 M | |
| Total Other Income Expense Net | -86.7 K | -91 K | |
| Net Loss | -8.1 M | -8.5 M | |
| Income Tax Expense | 13.4 K | 7.9 K | |
| Net Interest Income | -86.1 K | -90.4 K | |
| Interest Income | 20.3 K | 19.2 K | |
| Net Loss | -8.1 M | -8.5 M | |
| Net Loss | -25.71 | -27.00 | |
| Income Quality | 0.72 | 0.46 | |
| Net Income Per E B T | 0.90 | 0.80 |
BioAffinity Profitability Driver Comparison
Profitability drivers for BioAffinity Technologies are the financial and operational factors that most directly influence its earnings. Investors must contend with a wide range of external shocks - from regulatory changes to commodity price swings - that can disrupt BioAffinity Technologies' financial results.
Earnings per Share Projection vs Actual
Use BioAffinity Technologies in pair-trading
Pair trading with BioAffinity Technologies can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
BioAffinity Technologies Pair Trading
bioAffinity Technologies Warrant Pair Trading Analysis
Using correlated positions as BioAffinity Technologies substitutes during tax-loss harvesting allows investors to capture a tax benefit without disrupting portfolio allocation. The key is finding instruments that track bioAffinity Technologies Warrant closely enough to maintain equivalent risk and return.
The correlation of BioAffinity Technologies with other assets is a key diversification metric. Pairing BioAffinity Technologies with uncorrelated or negatively correlated instruments can reduce overall portfolio volatility without necessarily reducing expected returns.
Correlation analysis and pair trading evaluation for BioAffinity Technologies can be used to frame hedging context. The view can be extended across sectors or other related groups.Use Investing Themes to Complement your BioAffinity Technologies position
Using bioAffinity Technologies Warrant inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Did You Try This Idea?
Run Artificial Intelligence Thematic Idea Now
Artificial Intelligence
Technology companies, funds, and ETFs across multiple industries that are involved in research or development in the field of reasoning, learning, natural language processing and perception as well as its application to science and commerce. This theme may also include entities involved in cybernetics and cognitive brain simulation field. The Artificial Intelligence theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Artificial Intelligence Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioAffinity Stock Analysis
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets |